Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

NeuroVision vs Standard Neuromonitoring

NCT: NCT04639297 · RECRUITING

NCT IDNCT04639297
StatusRECRUITING
Start Date2020-09-28
Completion2027-12-20

Brief Summary

The purpose of this study is to perform a prospective, randomized, controlled clinical trial to assess the utility of IONM in patients undergoing primary, single or multilevel lateral spinal procedures. Subjects will be randomized to undergo a lateral spine surgery with the use of NeuroVision® IONM or conventional hospital based IONM to assess incidence of new-onset neurological injury.

Frequently Asked Questions

What is NeuroVision vs Standard Neuromonitoring?

NeuroVision vs Standard Neuromonitoring is a clinical trial registered under NCT04639297. Current status: RECRUITING.

What is the status of NCT04639297?

The current status of NCT04639297 (NeuroVision vs Standard Neuromonitoring) is: RECRUITING.

When did NeuroVision vs Standard Neuromonitoring start?

NeuroVision vs Standard Neuromonitoring started on 2020-09-28.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.